secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANGIODYNAMICS INC (ANGO)
CIK:        0001275187
Form:       8-K
Filed at:   2026-10-08T11:16:17+00:00
Accession:  0001140361-26-039019
Event type: leadership
Sentiment:  neutral
Materiality: 0.62
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

AngioDynamics names Eric Honroth President & CEO effective Nov 2, 2026; Jim Clemmer retires after 10 years
--------------------------------------------------------------------------------

- Honroth, 55, joins as President, CEO and board member on Nov 2, 2026, succeeding Jim Clemmer, who departs the board that day and stays on as a consultant.
- Honroth was Global President, Life Science at Getinge and previously ran Getinge's $1.2B North American business; earlier roles at Abbott Vascular, Becton Dickinson, CareFusion, Boston Scientific.
- Pay package: $735,000 base salary, 95% bonus target, $1,487,116 long-term incentive award, $450,000 RSU replacement grant, $350,000 sign-on bonus, $10,000/month commuting stipend.
- Severance: 18 months base salary and 18 months health coverage if terminated without cause; a Change in Control triggers 24 months salary, lump-sum target bonus and full equity vesting.
- Clemmer consulting fee is $30,000/month to Nov 2, 2027; retention pacts with all named executives except Clemmer accelerate RSUs and pro-rate PSUs. Director Howard Donnelly to retire at term end.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1275187/000114036126039019/0001140361-26-039019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1275187/000114036126039019/ef20083270_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-039019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer